Many devices are available to assess cardiac output (CO) in critically ill patients and in the operating room. Classical CO monitoring via a pulmonary artery catheter involves continuous cardiac output (CCO) measurement. The second generation of Flotrac/Vigileo TM monitors propose an analysis of peripheral arterial pulse waves to calculate CO (APCO) without calibration. The aim of our study was to compare the CO between the Swan Ganz catheter and the Vigileo TM . In this observational study, nine patients undergoing coronary artery bypass grafting were prospectively included. APCO, mean (CCO) and instantaneous CO (ICO) were measured. Perioperative and postoperative assessments were performed up to 24 hours post-surgery. Measurements were recorded every minute, resulting in the collection of 6492 data pairs. Comparison of APCO and ICO showed a limited bias of -0.1 l/min but an important percentage error of 48%. Corresponding values were -0.1 l/min and 46% for the APCO versus CCO comparison, and 0 and 17% for ICO versus CCO comparison. Large inter-individual variability does exist. During cardiac surgery and after leaving the operating room, Vigileo TM is not clinically equivalent to continuous thermodilution by pulmonary artery catheter. Nevertheless, the connection between CCO and ICO relates the difference between APCO and CCO more to the different algorithms used. Further efforts should be concentrated on assessing the ability of this device to track changes in cardiac output.
Many devices are available to assess cardiac output (CO) in critically ill patients and in the operating room. While the continuous thermodilution technique using a pulmonary artery catheter (PAC) is used widely and is considered to be equivalent to bolus thermodilution 1,2 , less invasive methods are desirable. Indeed, the benefit of right heart catheterisation is unclear 3, 4 . The second generation of Flotrac/Vigileo™ monitors (Edwards Lifesciences, Irvine, CA, USA, version 1.07), which is improved when compared with the first version 5 , uses an analysis of peripheral arterial pulse waves to calculate CO, averaging 20-second windows over two minutes. Direct calibration is replaced by a calibration algorithm, including parameters such as vascular compliance and peripheral resistance; in version 1.07 a new calibration coefficient is calculated every minute. This new device has already been studied but its validity is uncertain, particularly in the operating room. Indeed, sympathetic stimulation and changes in waveform morphology might alter the measurements 6 . The aim of our study was to determine the accuracy of the Vigileo™ monitor within the first 24 hours of off-pump coronary artery bypass, in comparison with PAC continuous thermodilution.
METHODS

Patients
Institutional ethical committee approval was obtained in order to include patients scheduled for off-pump coronary artery bypass. Informed consent was not necessary because the usual periand postoperative protocol was respected during the study; PAC and arterial radial catheterisation are usually performed during this kind of surgery in our unit. Nine patients, who underwent coronary artery bypass grafting without cardiopulmonary bypass, were included prospectively from March 2006 to May 2007. A condition necessary for recruitment was the availability of the clinician executing the protocol throughout the procedure. Patients with cardiac rhythm disturbance or significant valvular disease were excluded.
Conditions of monitoring
In the operating room, patients received usual monitoring: pulse oximetry, five-lead electrocardiogram, capnography, blood temperature and radial arterial pressure. CO monitoring was started after the induction of anaesthesia which was carried out and continued with propofol, sufentanil and cisatracurium. Mechanical ventilation was controlled to maintain normocapnia (expiratory PCO 2 32 to 35 mmHg), without positive endexpiratory pressure. A standard set for arterial access was placed in the radial artery and a Swan-Ganz™ PAC (Swan-Ganz CCOmbo; Edwards, Irvine, USA) was introduced through the right internal jugular vein.
Arterial access was connected to a Vigileo™ monitor and the PAC was connected to a Vigilance™ monitor (Edwards Lifesciences, Irvine, CA, USA), the latter providing continuous CO (CCO) measurement and instantaneous CO (ICO), another method of determining CO with a PAC, where the values are not the average of several measures but are available on the Vigilance™ monitor as one measurement every 90 seconds. Both monitors were synchronised and data were registered every minute after in vivo PAC calibration: CCO continued for over 10 minutes using the Vigilance™ monitor, ICO, Vigileo™ CO (APCO) and SvO 2 . Measurements were recorded during the perioperative and postoperative period (first 24 hours). Postoperative care took place in the intensive care unit.
Statistical analysis
All data pairs in each group were compared by linear regression and the Bland and Altman method 7 . Bias was defined as the mean difference between CCO and APCO. Precision was given by one standard deviation (SD) of the bias. Limits of agreement were calculated arbitrarily as ±1.96 SD of the bias, according to tradition.
The percentage error was that proposed by Critchley and Critchley 8 : 1.96 SD/mean CO demonstrated in a meta-analysis that the difference between two methods of CO assessment might be considered clinically acceptable if the results lie within a percentage error of 30%. Acceptance of such precision or limits of agreement depends on a judgement.
The expected number of data pairs per patient was large, and each observation is close to another. To estimate intra-individual variability and reproductibility, we calculated intraclass correlation coefficient 9 : the larger the intraclass correlation, the more reliable the tested device.
Interpersonal variability was investigated by examining individual demographic data with three summary measurements 10 , linear regression coefficient, bias and percentage error. To evaluate taBle 1 Demographic and clinical characteristics. Data are given as mean ± SD (standard deviation).
Age (y) 69±9
Gender (M/F) 8/1
Body surface area (m²) 1.86±0.2
Left ventricular ejection fraction (%) 49±12
Body temperature in operating room (°C) 35.8±0.5
Length of surgery (min) 255±109
Preoperative haematocrit (%) 37±1
Use of inotropic drug (number of patients) 4
Use of vasopressive treatment (number of patients) 5
M=male, F=female. ICO determination by PAC, analysis was also carried out comparing CCO and ICO.
RESULTS
Patients
The characteristics of the patients are shown in Table 1 . A total of 6492 data pairs were collected. Table 2 summarises the haemodynamic data for the patients. No adverse events from performing the monitoring were noted during the study.
Cardiac output measurements
The results of CO measurement are summarised in Table 3 . The comparison between APCO and CCO showed a bias of -0.10 l/min, a precision of 1.13 l/min and a percentage error of 46% (Figure 1 ), a linear regression coefficient of 0.14 and an intraclass correlation of 0.34. The comparison between APCO and ICO found a bias of -0.09 l/min, a precision of 1.18 l/min and percentage error of 48%, a linear regression coefficient of 0.14 and an intraclass correlation of 0.35. Comparison between CCO and ICO showed a bias of 0.03 l/min, a precision of 0.42 l/min and a percentage error of 17%, a linear regression coefficient of 0.87 and an intraclass correlation of 0.93. Individual analysis is also shown in Table 4 and Figure 2 represents individual error percentage and linear regression.
DISCUSSION
This study assessed the Vigileo™ monitor compared to thermodilution by PAC for the measurement of CO in the perioperative and postoperative periods and investigated the conditions that might alter the accuracy of the device. An acceptable bias but an important percentage error was found in comparison with thermodilution by PAC, which is clinically unacceptable according to the Critchley and Critchley criteria. The difference was consistent and similar for the APCO versus CCO and APCO versus ICO comparisons. These results are comparable with previous studies. Linear regression coefficient is five times smaller and intraclass correlation coefficient is three times as small in Vigileo™ assessment compared with the thermodilution techniques. Reproducibility therefore seems lower in Vigileo™ than in PAC, however limitations concerning the reliability of CO measurement by PAC itself should be taken into consideration.
The concept of Flotrac/Vigileo™ has already been studied in 16 different clinical settings 6, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Fourteen compared Vigileo™ (radial or femoral arterial cannulation) to thermodilution by PAC, bolus or continuous method, but never instantaneous PAC determination as in our study. Patients were enrolled in the intensive care unit and operating room, mainly in cardiac surgery. Between six and 84 patients were recruited, giving a number of measurements between 56 and 562. Studies showed poor correlation between the methods, with a bias of between -0.38 l/min 12 and 0.46 l/min 11 , and a percentage error of 27 12 to 51% 11 , which being above 30%, is clinically unacceptable according to Critchley and Critchley. Of the 16 different publications, 10 gave acceptable correlations and five determined that the new monitor was not clinically acceptable. Having made the calculation of the criteria of Critchley and Critchley ourselves, we found that only three of these studies revealed clinical reliability 12, 23, 25 . Among the seven authors having considered the device as acceptable but presenting a percentage error of more than 30%, only two had included this calculation in their study: de Waal 15 found an almost acceptable percentage error of 33%; Lorsomradee 6 used a criterion of 50% but the observation of subgroups incited them to conclude that in situations where the arterial pressure waveform had changed, agreement between the techniques may be altered. Finally, Zimmermann 20 performed a second statistical variation close to but different from the criterion of Critchley and Critchley. All these reports show the importance of the use of a predefined and objective criterion and limitations regarding the reliability of all continuous cardiac techniques.
Other methods currently available to measure CO include PiCCO™, NICO™ and transoesophageal Doppler ultrasonography. In original studies and meta-analyses, PiCCO™ showed limits of agreement of ±1.5 l/min compared to thermodilution by PAC 26, 27 and is considered to be clinically acceptable in the operating room. The main evaluation of the NICO™ system demonstrated poor agreement of ±1.8 l/min 28 , giving a percentage error of 40%. The meta-analysis of Dark et al 29 dealing with transoesophageal Doppler found limits of agreement of 52%, which are not acceptable. Dealing with bias and percentage error, Vigileo™ accuracy is comparable to other devices, but is not really clinically acceptable either. Two points should be clarified: on one hand, new devices of haemodynamic assessment are compared to a device that itself is possibly inaccurate, and on the other hand there has not yet been any international agreement on the gold standard for CO measurements. Nevertheless, PAC is often considered to be the best reference method 30 . Conversely, tracking changes in cardiac performance, which are rarely assessed, may reveal more information. Despite the known vascular complications of the Swan-Ganz™ catheter, this device allows the assessment of filling pressure and peripheral resistance.
The results vary from patient to patient, with some cases giving poor correlation, from 30 to 55% error, and 0.51 to zero for the linear regression coefficient. Interindividual variability seems to be important in this trial. This may indicate that there are some circumstances where reliability is modified. As an example, two authors 18, 22 included haemodynamically unstable patients in intensive care, finding a percentage error of 58 and 68% compared with PiCCO™.
In perioperative conditions, rapid haemodynamic changes are frequent. It is desirable that these cases are detected. CCO is the average of eight measurements over a period of 10 minutes. That is why it is more relevant to compare APCO with ICO, which is calculated every two minutes, even if ICO only depends on one measurement and Vigileo™ is averaged over two minutes.
The comparison between CCO and ICO is interesting as it demonstrates that the difference between CCO and Vigileo TM does not involve only a time parameter. ICO is an instantaneous measure provided by the Vigilance™ every 90 to 120 seconds. If CCO by PAC had been late to detect haemodynamic changes in comparison with the new device, ICO and Vigileo™ would have given more similar results. However, this was not the case. The two types of softwares studied in this setting used different algorithms.
Mayer et al 11 reported the ability of Vigileo™ to track rapid changes in CO. Also, in the study of Cannesson et al 19 , there was a significant relationship between percent change in PAC and Vigileo™ following volume expansion. The significant difference between Vigileo™ and thermodilution by PAC in our study must be adjusted for this parameter. In fact, we cannot exclude the possibility that Vigileo™ might be more sensitive. This software involves CO measurement every 20 seconds, whereas the Vigilance TM uses the PAC to make a measurement every 90 to 120 seconds.
The physiological model used by Vigileo™ integrates several parameters representing the flowpressure relationship: heart rate, standard deviation of arterial pressure, a scale factor proportional to vascular and peripheral resistance estimated at a few time-points combined over the arterial pressure waveform (mean, standard deviation, skewness and kurtosis [the degree of peakedness of a distribution]), pressure-dependent Windkessel compliance based on Langewouter's study 31 , body surface area and specific patient characteristics. The importance attributed to each parameter is unknown, making the analysis difficult 32 . Nevertheless, it is obvious that measurements calculated with a variable function are only an approximation of reality.
We expect a new haemodynamic monitoring device to prove its utility against existing methods. The difficulty is its inability to be compared with a true reference, and to occur in a context where CO singly used has no proven benefit. Therefore, a new device has to present advantages with regard to precedents.
CO is not sufficient to evaluate haemodynamic situations. Therapy in the operating room should be guided by assessment including clinical and paraclinical factors. These paraclinical factors should include CO measured by a fast device detecting changes, and dynamic indicators if possible. Data provided by Vigileo™ include CO, stroke volume and stroke volume variation; however these latter two data have not yet been validated with the Vigileo™ system. A concomitant central venous pressure catheter (whose signal is interfaced with the monitor) allows the calculation of systemic vascular resistance, but this has not been validated either.
Complete monitoring includes the measurement of central venous O 2 saturation in the superior vena cava through the central venous catheter. Here we note that mixed venous SvO 2 is used instead of central venous SvO 2 , which are not strictly equivalent 33 . However, this complete system is invasive, whereas the main advantage of Vigileo™ is its reduced invasiveness.
In conclusion, the advantages of Vigileo™ are its reduced invasiveness and that it does not require any calibration. In our clinical setting, we report a significant difference with continuous thermodilution by PAC, especially in the operating room. Further studies should be directed towards the ability of this device to track haemodynamic changes.
